Short description
Covaxx is a biotech company developing diagnostic tests and vaccines designed to cure COVID-19.
Description
Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity's Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.
Total funding
$$43214321
Sign in for full access
Location
Hauppauge, New York, United States, North America
Founded on
January 1, 2020
Closed on
March 2, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe
Sign in for full access
Founders
Lou Reese, Mei Mei Hu, Peter Diamandis, Wang Changyi